Global Gadolinium-153 Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Gadolinium-153 market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
In 2025, global Gadolinium-153 production was approximately 1,500 grams, with a global average market price of around $6,400 per gram. Total global production capacity for Gadolinium-153 reached approximately 3,400 grams in 2025. The industry's average gross profit margin for this product stood at approximately 50%. Gadolinium-153 (^153Gd) is an artificial radioactive isotope of gadolinium, a lanthanide element with an atomic number of 64 and a mass number of 153. It is mainly produced by neutron irradiation of natural gadolinium targets or enriched gadolinium isotopes in nuclear reactors. ^153Gd has a half-life of approximately 240 days (around 7.8 months) and decays through electron capture (EC), emitting characteristic X-rays at approximately 41 keV and 103 keV. Due to its low-energy radiation emission, stable output characteristics, and suitable half-life, ^153Gd is widely used for medical imaging equipment calibration, bone densitometer calibration, radiation detector calibration, and scientific research applications.
The upstream of the gadolinium-153 industry chain mainly includes the supply of natural gadolinium resources, gadolinium isotope separation, preparation of enriched gadolinium targets, and nuclear reactor irradiation capabilities. Natural gadolinium primarily originates from rare earth minerals such as monazite and xenotime, with production and supply concentrated in rare earth resource regions such as China, the United States, and Australia. Industrial production of ^153Gd typically uses high-purity gadolinium oxide (Gd₂O₃) or enriched gadolinium isotopes as target materials, generating ^153Gd through neutron capture reactions in research or commercial nuclear reactors. Due to the involvement of nuclear material management, irradiation facilities, and radiochemical processing, the upstream has high technical barriers and regulatory requirements. The midstream of the industry chain mainly includes the irradiation production of gadolinium-153, chemical separation and purification, activity detection, and the manufacture of sealed radioactive sources. The ^153Gd produced by nuclear reactions requires radiochemical treatment to remove impurity isotopes and improve radioactivity purity and specific activity. It is then prepared into different forms of radioactive sources according to application requirements, such as sealed sources, calibration sources, or research standard sources. Since gadolinium-153 is primarily used for equipment calibration rather than direct human treatment, its products typically need to meet stringent radioactive source certification, transportation regulations, and quality control requirements. Major global suppliers are concentrated in institutions with nuclear reactor resources, radioactive isotope production qualifications, and sealed source manufacturing capabilities. Downstream applications of gadolinium-153 are mainly concentrated in medical equipment calibration, radiation detection, and scientific research. The most significant application is in the calibration of bone densitometers (DXA) and some X-ray detection equipment, which improves the measurement accuracy of medical imaging equipment by stably releasing low-energy X-rays to simulate the absorption characteristics of human tissue. In addition, ^153Gd is also used in gamma-ray detector calibration, nuclear radiation monitoring equipment testing, industrial measurement systems, and isotope research. With the increasing global stock of medical imaging equipment, rising quality control requirements in nuclear medicine, and growing demand for high-precision radiation detection, the value of gadolinium-153 as a standard calibration source continues to rise.
The increasing global installed base of medical imaging equipment, particularly bone densitometers (DXA), X-ray systems, and radiation detection devices, is driving demand for highly stable radioactive calibration sources. Gadolinium-153 offers advantages including an appropriate half-life, stable energy emission, and well-defined X-ray characteristics, making it an important calibration source for bone densitometers and related imaging systems. With population aging, rising demand for osteoporosis screening, and stricter medical equipment quality-control standards, the application value of ^153Gd in medical calibration and measurement continues to increase.
In addition to medical equipment calibration, ^153Gd is widely used for the calibration of radiation detectors, gamma-ray measurement systems, nuclear safety monitoring equipment, and scientific research platforms. The development of nuclear medicine, industrial non-destructive testing, radiation protection, and nuclear safety applications is increasing demand for standardized and highly reliable radioactive sources. With the expansion of nuclear facilities, stricter radiation monitoring regulations, and upgrades in laboratory metrology systems, ^153Gd is becoming increasingly important as a stable calibration source.
The development of the ^153Gd industry relies on high-purity gadolinium material preparation, isotope enrichment, reactor irradiation, and radiochemical separation technologies. In recent years, isotope production capabilities from research reactors and commercial nuclear facilities have improved, while automated radioactive source manufacturing, quality inspection, and safety encapsulation technologies have enhanced product consistency and supply reliability. In the future, companies and institutions with reactor resources, isotope production licenses, and sealed-source manufacturing capabilities will maintain competitive advantages in the global supply chain.
Report Scope
This report is a detailed and comprehensive analysis for global Gadolinium-153 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gadolinium-153 market size and forecasts, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Gadolinium-153 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Gadolinium-153 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Gadolinium-153 market shares of main players, shipments in revenue ($ Million), sales quantity (Gram), and ASP (US$/g), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gadolinium-153
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gadolinium-153 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Rosatom, ORNL(DOE IP), Eckert & Ziegler, Buyisotope(Neonest AB), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Gadolinium-153 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Activity Concentration＜60Ci/g
Activity Concentration≥60Ci/g
Market segment by Product Form
Gadolinium-153 Sealed Radioactive Source
Gadolinium-153 Solution
Market segment by Encapsulation Form of Radioactive Source
Gadolinium-153 Point Source
Gadolinium-153 Planar Source
Gadolinium-153 Rod Source
Market segment by Production Technology Pathway
Reactor Neutron Irradiation
Enriched Isotope Target Preparation
Natural Gadolinium Target Preparation
Scientific Research/Experimental Target Preparation
Market segment by Application
Nuclear Medicine
Scientific Research
Major players covered
Rosatom
ORNL(DOE IP)
Eckert & Ziegler
Buyisotope(Neonest AB)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Gadolinium-153 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gadolinium-153, with price, sales quantity, revenue, and global market share of Gadolinium-153 from 2021 to 2026.
Chapter 3, the Gadolinium-153 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gadolinium-153 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Gadolinium-153 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gadolinium-153.
Chapter 14 and 15, to describe Gadolinium-153 sales channel, distributors, customers, research findings and conclusion.